Accounting Manager, Relay Therapeutics
3-5 days a week in office (Cambridge, MA)
AI-driven drug discovery platform
Be an early applicant
AI-driven drug discovery platform
201-500 employees
Be an early applicant
3-5 days a week in office (Cambridge, MA)
201-500 employees
Company mission
Relay Therapeutics' mission is to create new possibilities in drug discovery focused on precision oncology and genetic disease through its AI and ML-driven computing approaches.
Role
Who you are
- You earned your Bachelor’s or Master’s in Accounting and are licensed as a CPA
- You have 3 to 6 years of experience working with public companies, preferably in life sciences
- You have experience at a public accounting firm, with exposure to reporting with the U.S. SEC
- You are proficient with U.S. GAAP and familiar with accounting practices in the life sciences industry
- Do you have experience with Active Disclosure, NetSuite, ADP, and E-Trade? This would be a plus
- You are proficient with Microsoft Office, including strong skills in Excel and PowerPoint
- You have experience working in a fast-paced company, again preferably in life sciences
- You exhibit attention to detail and follow-up skills to identify and resolve issues independently
- You are known for your ability to multi-task, work cross-functionally, and meet deadlines
- You are a collaborative business partner and adept in building cross-functional relationships
- You are an effective communicator with excellent written and verbal communication skills
- You are an awesome teammate with hustle, determination, and a customer-centric approach; and
- You exhibit the highest degree of integrity and ethics
What the job involves
- We are looking for a proactive individual to join the Relay Tx Accounting Team. In this role, you’ll play a key role in a number of our core Accounting workstreams including the monthly close process; SEC reporting; payroll and stock plan administration. You’ll partner closely with Finance, Legal, HR, and the Company’s external auditors. You’ll be a critical member of the team at Relay Tx, particularly as we continue to transform as a company
- Monthly Close and GL: You’ll play a role in the close process for a number of GL Accounts
- Financial Reporting: You’ll play a role in guiding processes around periodic reporting with the SEC
- Payroll & Stock Administration: Supporting Relay Tx’s payroll & stock plan administration activities. Although you might have no previous experience in overseeing and managing payroll administration, our current service model with our service provider would enable you to learn and gain expertise
- Other responsibilities include assisting in the preparation of Audit Committee Materials; collaborating with external auditors; developing cross functional relationships to maintain close collaboration with the business
Our take
Discovering new drugs is essential in improving how diseases are treated, but existing methods are outdated. Many diseases are highly complex and have so far been impossible to treat with drugs, but developments in AI-driven computing present the potential to change this.
Relay Therapeutics provides an AI-driven drug discovery platform called Dynamo that uses cutting-edge experimental computational approaches to identify disease treatments that have previously been deemed untreatable. The platform's AI approach is driven by a pipeline of therapeutic candidates which hold an initial focus on precision oncology and genetic disease treatment.
AI is being used within the medical industry to aid in a wide variety of scenarios such as facility optimization and automated diagnoses, but Relay Therapeutics has smartly applied it to drug discovery. Through this more targeted approach, the company aims to rapidly develop genetic disease treatments and optimize the process of precision oncology, with plans to expand into further disciplines in the future. It's continued development of new products shows that Relay is keeping up the pace.
Steph
Company Specialist at Welcome to the Jungle
Insights
9% employee growth in 12 months
Company
Funding (last 2 of 3 rounds)
Dec 2018
$400m
SERIES C
Dec 2017
$63m
SERIES B
Total funding: $520m
Company benefits
- Medical coverage
- Dental coverage
- Vision coverage
- Life, AD&D, and disability insurance
- Flexible spending accounts
- 401K retirements savings
- Commute reimbursements
- Parental benefits
- Time off and vacation
Company HQ
Wellington-Harrington, Cambridge, MA
Leadership
Mark Murcko
(Founder)Principal at Disruptive Biomedical, LLC since 2011. Senior Lecturer at the Department of Biological Engineering for MIT since 2012.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job